Twitter

Facebook

Youtube

RSS

Hindi News | Samay | UP/Uttarakhand | MP/Chhattisgarh | Bihar/Jharkhand | Rajasthan | Aalami Samay
  Rashtriya Sahara Roznama Sahara
Vaccination drive in Delhi at 81 places, 4 days a week: CM Kejriwal
Last Updated : 14 Jan 2021 02:56:14 PM IST
Delhi Chief Minister Arvind Kejriwal
Delhi Chief Minister Arvind Kejriwal

 

Delhi Chief Minister Arvind Kejriwal on Thursday said that the vaccination drive against coronavirus will be carried out at 81 centres across the national capital from January 16, on four days in a week.

Arrangements are in place to vaccinate 100 person daily at each of these 81 centres, ensuring inoculation of over 8,000 persons every day. The number of centres will be subsequently increased to 175, and then to 1,000, he added.
 
The vaccination in the first phase will be conducted on Mondays, Tuesdays, Thursdays and Saturdays.
 
Addressing a press conference virtually, two days ahead of the launch of the world's largest vaccination drive in India, Kejriwal said that the vaccination process for other diseases will be taken up on Wednesdays and Fridays so that these did not suffer.
 
"The vaccination drive against coronavirus will begin from January 16 across the country and the Delhi government has made all preparations. I reviewed the preparations today (Thursday) in a meeting with officials," Kejriwal said.
 
The Aam Aadmi Party leader said that the Delhi government had received 2.74 lakh vaccine doses so far. "As two doses will be administered to each person, and given the 10 per cent extra doses given by the Centre to deal with damage cases, these vaccine doses will be sufficient for 1.30 lakh healthcare workers," Kejriwal said.
 
Kejriwal said he hoped that the Centre will provide more doses very soon as the numbers were not enough to inoculate all healthcare workers.
 
In all, 2.40 lakh healthcare workers have registered for the vaccination drive in Delhi in the first phase.
 
The Drug Controller General of India has approved 'Covishield' and 'Covaxin' vaccines for emergency use. The Oxford University and AstraZeneca have developed 'Covishield', which has been manufactured in India by Serum Institute of India in Pune. Bharat Biotech has developed 'Covaxin'.


IANS
New Delhi
For Latest Updates Please-

Join us on

Follow us on


What binds the two most talked about nations - India and Pakistan together? What makes the

Kapil Sharma, the renowned stand-up comedian, television host, and actor, was honoured wit

LG Electronics Inc said on Wednesday that it will introduce new C with its artificial inte

 

Samay Live
Samay Live
Samay Live
Samay Live
Samay Live
Samay Live
Samay Live
Samay Live

172.31.16.186